Stock DMSIM DMS IMAGING
Add to a list
To use this feature you must be a member
Log inSign up

All News DMS Imaging

Equities

DMSIM

BE0974289218

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:13 2024-04-30 EDT 		5-day change 1st Jan Change
0.024 EUR +33.33% Intraday chart for DMS Imaging +17.65% +2.13%
2023 DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DMS Imaging : Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024
PU
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Dms Imaging : DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.
AT
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Dms Imaging : Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives
AT
Dms Imaging : 2022 revenue: EUR 35.3 m - 2023 targets and perspectives
AT
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy
MT
Dms Imaging : Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging
AT
Dms Imaging : 2022 bi-annual results
AT
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
DMS Imaging : Annual Financial Report 2021
PU
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
DMS Imaging: Publication Regarding a Transparency Notification
BU
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech
MT
Global markets live: Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...
Our Logo
ASIT biotech : 2020 annual financial report
PU
Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.
AQ
ASIT biotech : presents its 2020 half year results and provides a business update until end 2020
PU
ASIT biotech : 2020 interim financial report as of June 30, 2020
PU
ASIT biotech : Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DMSIM Stock
  4. News DMS Imaging